Dr. Leigha Sharp , MD
Dermatology โข Austin, TX
4419 Frontier Trl Ste 110
Austin, TX 787451567
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 20, 2016; this date does not establish years in practice.
-
Published CMS data list 5,352 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 โ Destruction of precancer skin growth, 2-14 growths: 2,040 service units.
- 99213 โ Established patient outpatient office visit: 625 service units.
- 17000 โ Destruction of precancer skin growth, 1 growth: 578 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,445 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Clobetasol Propionate โ 288 prescription fills, including refills.
- Ketoconazole โ 194 prescription fills, including refills.
- Triamcinolone Acetonide โ 128 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 27 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Dermatology in Austin, TX (2024, 66 clinicians with data). Median for this group: 1,599. Middle half: 772 to 3,972.
More Medicare Part B services than 75% of clinicians listed under Dermatology in Texas (2024, 827 clinicians with data). Median for this group: 2,195. Middle half: 1,085 to 4,742.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 238 in 2020 to 5,352 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
4419 Frontier Trl Ste 110
Austin, TX 787451567
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Buda, TX; Midland, TX. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Southwest Skin And Vein Center Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Texas Tech University Health Science Center School Of Medicine
2016
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
849 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $341,125 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $244,966 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
1,760 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$825,998 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,987.47 across 107 records.
By nature of payment
- Food and Beverage: $1,982.47 across 106 records.
- Education: $5.00 across 1 record.
Reporting-company totals (3 largest of 15)
- UCB, Inc.: $506.07 across 18 records.
- Regeneron Pharmaceuticals, Inc.: $270.73 across 14 records.
- LEO Pharma Inc.: $222.40 across 11 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
10 years (graduated 2016)
CMS Doctors and Clinicians data list 2016 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Sharp has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Sharp as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Austin and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Dermatology in Austin, TX (2024, 66 clinicians with data). Median for this group: 1,599. Middle half: 772 to 3,972.
More Medicare Part B services than 75% of clinicians listed under Dermatology in Texas (2024, 827 clinicians with data). Median for this group: 2,195. Middle half: 1,085 to 4,742.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Dermatology in Austin, TX (2024, 66 clinicians with data). Median for this group: $96,696. Middle half: $44,145 to $200,151.
A higher Medicare-allowed amount than 75% of clinicians listed under Dermatology in Texas (2024, 827 clinicians with data). Median for this group: $135,212. Middle half: $65,517 to $291,099.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Dermatology in Austin, TX (2024, 66 clinicians with data). Median for this group: $66,167. Middle half: $32,634 to $137,527.
A higher Medicare payment amount than 75% of clinicians listed under Dermatology in Texas (2024, 827 clinicians with data). Median for this group: $95,715. Middle half: $45,692 to $209,369.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Dermatology in Austin, TX (2024, 71 clinicians with data). Median for this group: 319. Middle half: 137 to 712.
More Part D prescriptions than 85% of clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: 486. Middle half: 202 to 949.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Austin, TX (2024, 71 clinicians with data). Median for this group: $75,369. Middle half: $2,974 to $183,429.
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Texas (2024, 922 clinicians with data). Median for this group: $81,547. Middle half: $6,986 to $226,319.
100 active clinicians are listed under Dermatology with a practice address in Austin, TX (1,173 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Austin
5% of these 100 clinicians have the CMS telehealth indicator.
70% of these 100 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 2149% from 238 in 2020 to 5,352 in 2024.
- 2020: 238
- 2021: 3,190
- 2022: 3,481
- 2023: 5,433
- 2024: 5,352
-
Medicare-allowed amount
Medicare-allowed amount increased 2820% from $11,682 in 2020 to $341,125 in 2024.
- 2020: $11,682
- 2021: $204,272
- 2022: $209,694
- 2023: $335,162
- 2024: $341,125
-
Paid by Medicare
Paid by Medicare increased 2769% from $8,540 in 2020 to $244,966 in 2024.
- 2020: $8,540
- 2021: $150,384
- 2022: $150,286
- 2023: $241,854
- 2024: $244,966
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 563% from 218 in 2020 to 1,445 in 2024.
- 2020: 218
- 2021: 485
- 2022: 783
- 2023: 1,118
- 2024: 1,445
-
30-day fills
30-day fills increased 663% from 231 in 2020 to 1,760 in 2024.
- 2020: 231
- 2021: 555
- 2022: 979
- 2023: 1,390
- 2024: 1,760
-
Part D drug cost
Part D drug cost increased 7977% from $10,226 in 2020 to $825,998 in 2024.
- 2020: $10,226
- 2021: $17,503
- 2022: $114,187
- 2023: $634,855
- 2024: $825,998
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $674.66 in 2021 to $1,987.47 in 2025.
- 2021: $674.66
- 2022: $609.39
- 2023: $992.37
- 2024: $1,224.00
- 2025: $1,987.47
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 107 records totaling $1,987.47.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $116.31 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $115.43 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $107.87 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $44.20 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $32.42 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $31.39 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $30.71 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $30.25 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $28.73 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $28.73 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $28.43 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $28.16 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $28.08 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $27.65 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $27.00 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TREMFYA | General | $26.67 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $26.56 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $25.74 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $24.99 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $24.94 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $24.50 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $24.13 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $24.00 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ADBRY | General | $23.69 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
COSENTYX | General | $23.57 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2019โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2020โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
2,040 | 322 | $13.26 | $6.84 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
625 | 426 | $181.38 | $93.56 |
|
17000
Destruction of precancer skin growth, 1 growth
|
578 | 413 | $135.10 | $50.05 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
575 | 379 | $254.12 | $130.95 |
|
17110
Destruction of skin growth, 1-14 growths
|
469 | 361 | $226.90 | $110.54 |
|
11102
Biopsy of related skin growth, first growth
|
272 | 235 | $200.79 | $82.74 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
121 | 80 | $338.36 | $175.80 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
101 | 101 | $221.29 | $113.19 |
|
11103
Biopsy of related skin growth, each additional growth
|
86 | 56 | $100.31 | $52.13 |
|
17262
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
|
82 | 62 | $357.43 | $167.26 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
74 | 74 | $331.29 | $168.99 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
63 | 58 | $112.83 | $58.39 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
63 | 25 | $2.01 | $0.99 |
|
17261
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
|
47 | 34 | $299.51 | $119.02 |
|
17111
Destruction of skin growth, 15 or more growths
|
32 | 23 | $267.07 | $137.94 |
|
11900
Injection into skin growth, 1-7 growths
|
27 | 20 | $115.18 | $45.51 |
|
10040
Acne surgery
|
23 | 21 | $232.17 | $112.34 |
|
96372
Injection of drug or substance under skin or into muscle
|
22 | 13 | $29.19 | $15.14 |
|
12032
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
|
20 | 19 | $608.50 | $299.24 |
|
69100
Biopsy of ear
|
18 | 15 | $189.51 | $70.92 |
|
11301
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
|
14 | 13 | $241.14 | $111.35 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Clobetasol Propionate | Clobetasol Propionate | 288 | 8,638 | $11,309.21 | 158 |
| Ketoconazole | Ketoconazole | 194 | 5,805 | $2,413.23 | 81 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 128 | 3,679 | $1,065.72 | 91 |
| Dupixent Pen | Dupilumab | 74 | 2,058 | $316,630.09 | 11 |
| Hydrocortisone | Hydrocortisone | 68 | 1,752 | $286.70 | 44 |
| Finasteride | Finasteride | 67 | 5,072 | $414.19 | 21 |
| Minoxidil | Minoxidil | 59 | 4,388 | $360.80 | 19 |
| Metronidazole | Metronidazole | 53 | 1,530 | $1,697.36 | 22 |
| Ciclopirox | Ciclopirox | 47 | 1,418 | $1,017.48 | 28 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 43 | 1,868 | $2,001.08 | 31 |
| Tacrolimus | Tacrolimus | 42 | 1,010 | $4,789.51 | 21 |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 1,710 | $4,503.66 | โ |
| Tretinoin | Tretinoin | 40 | 1,305 | $1,869.59 | 23 |
| Valacyclovir | Valacyclovir Hcl | 32 | 866 | $959.26 | 25 |
| Otezla | Apremilast | 30 | 903 | $143,875.80 | โ |
| Clindamycin Phosphate | Clindamycin Phosphate | 27 | 820 | $890.24 | 12 |
| Taltz Autoinjector | Ixekizumab | 27 | 756 | $183,497.34 | โ |
| Prednisone | Prednisone | 25 | 637 | $143.65 | 18 |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 24 | 534 | $539.76 | 17 |
| Fluorouracil | Fluorouracil | 23 | 574 | $1,750.19 | 21 |
| Terbinafine Hcl | Terbinafine Hcl | 23 | 898 | $187.69 | 16 |
| Gabapentin | Gabapentin | 18 | 840 | $168.92 | โ |
| Mupirocin | Mupirocin | 17 | 400 | $121.07 | 16 |
| Minocycline Hcl | Minocycline Hcl | 16 | 464 | $307.17 | โ |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 14 | 381 | $542.94 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-12-31NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20200721001004
TX
6103240452
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Southwest Skin And Vein Center Pllc
14008 Shadowglen Blvd, Manor, TX 786533406
Phone: 5124447208
Southwest Skin And Vein Center Pllc
4419 Frontier Trl, Austin, TX 787451567
Southwest Skin And Vein Center Pllc
249 Sportsplex Dr, Dripping Springs, TX 786202350
Phone: 5124447208
Southwest Skin And Vein Center Pllc
4544 S Lamar Blvd, Austin, TX 787451500
Phone: 5124447208
Southwest Skin And Vein Center Pllc
211 B N Fm, Buda, TX 786103859
Phone: 7377173244
Secondary Practice Locations
5117 Sunmore Cir
Midland, TX 797075124
Phone: 4326892512
211b N Fm 1626 Ste 1a
Buda, TX 786103859
Phone: 7377173244
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Dermatology
Doctor of Medicine (M.D.)
Dermatology - MOHS-Micrographic Surgery
Doctor of Medicine (M.D.)
Dermatology
Dermatology
Dermatology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4419 FRONTIER TRL STE 110, AUSTIN, TX 787451567 (Tel: 5124447208)
Registered at 4419 FRONTIER TRL STE 110, AUSTIN, TX 787451567 (Tel: 5124447208)
Registered at 5117 SUNMORE CIR, MIDLAND, TX 797075124 (Tel: 4326892512)
Registered at 5117 SUNMORE CIR, MIDLAND, TX 797075124 (Tel: 4326892512)
Dermatology (license number reported to NPPES: TX S4686)
Registered at 4419 FRONTIER TRL STE 110, AUSTIN, TX 787451567 (Tel: 5124447208)
Registered at 4419 FRONTIER TRL STE 110, AUSTIN, TX 787451567 (Tel: 5124447208)
NPI status registered as active in NPPES database
Registered at 601 EAST 15TH STREET, UT AUSTIN DELL MEDICAL SCHOOL INTERNAL MEDICINE UMCB, AUSTIN, TX 78701 (Tel: 5123248355)
Registered at 601 EAST 15TH STREET, UT AUSTIN DELL MEDICAL SCHOOL INTERNAL MEDICINE UMCB, AUSTIN, TX 78701 (Tel: 5123248355)
Recorded as LEIGHA SHARP, MD
Student in an Organized Health Care Education/Training Program (license number reported to NPPES: TX 10056862)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Austin
- Dr. Blakely Richardson, DO
- Dr. Alison Messer, MD
- Dr. Jaculeen Dano, MD
- Dr. Heidi Prather, MD
- Dr. Grace Kimmel, MD
- Dr. Elizabeth Foley, DO
Mailing Address
4419 Frontier Trl Ste 110
Austin, TX 787451567
Phone: 5124447208